StonvexLoading…
StonvexStonvexStonvexCore line items from RYN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $276.52M | $483.04M | $365.86M | $188.81M |
Operating Income | $-45.65M | $83.34M | $56.31M | $14.60M |
Net Income | $-12.43M | $474.38M | $448.47M | $405.28M |
EPS (Diluted) | $-0.05 | $3.03 | $2.88 | $2.60 |
Total Assets | $7.75B | $3.40B | $3.49B | $3.51B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $681.66M | $842.94M | $919.58M | $892.26M |
Free Cash Flow OCF − CapEx | Not available | Not available | $157.96M | Not available |
Shares Outstanding | 301.68M | 161.43M | 153.87M | 154.76M |